Press Coverage
November 19, 2011 - Peter Miller, CEO of OptiNose, talks with The New York Times about his entrepreneur spirit.
I GREW up in East Falls, a neighborhood of northwest Philadelphia. My father spent his career as a radiologist, working and teaching at the Hospital of the University of Pennsylvania. My mother, who was a nurse, stayed at home to raise my three siblings and me.
Read More...
June 3, 2011 - OptiNose is Breathing Some New Life into Old Drugs
Peter Miller was sniffing around for his next entrepreneurial opportunity last summer when he decided to join OptiNose as CEO of the Bucks County company that has developed a new way to deliver medicine.
Read More...
May 25, 2011 - Radius, 3M Drug Delivery partner on osteoporosis drug; OptiNose wins award for nasal delivery;
Radius Health and 3M Drug Delivery Systems are getting together to develop a transdermal version of BA058, which is Radius' parathyroid hormone-related protein analog to treat osteoporosis.
Read More...
December 21, 2010 - Nose Spray that Eases A Migraine in Minutes
A pipe-like puffer device that blows powdered medicine up the nose could banish the pain of migraine in less than two hours.
Read More...
September 29, 2010 - OptiNose Aims High with Nasal Drug Delivery Device
Yardley-PA based OptiNose is hoping to use its nasal-spray device to revolutionize the way existing drugs are delivered, boosting efficacy, lowering dosages and potentially replacing vaccines all together.
Read More...
September 27, 2010 - Yardley Start-Up Hoping Medical Device Delivers
Peter Miller and Ramy A. Mahmoud have a shared definition of brilliant: an idea so "blindly simple" that, as Mahmoud puts it, one wonders why no one had thought of it before.
Read more...
August 11, 2010 - OptiNose Reveals Bi-directional Nasal Device Phase II Results
OptiNose, a provider of bi-directional nasal activity technology, has released positive Phase II trial results evaluating the bi-directional nasal device delivering fluticasone, a nasal steroid, which demonstrated to be effective in progressively reducing the size or eliminating nasal polyps in patients with chronic rhinosinustis (CRS) with nasal polyps.
Read More...
Thursday, June 10, 2010 - OptiNose Lands $48.5 Million in Funding, New CEO
One of the local founders of Take Care Health Systems has jumped into the top job of another health-care company that’s moving here.
Read More...
